Evidence map›Paper›PMID 25620857›Full record

ArticleProceedings of SPIE--the International Society for Optical Engineering2013

Ti Zhang, Huizhong Cui, Chia-Yi Fang, Janggun Jo, Xinmai Yang, Huan-Cheng Chang, M Laird Forrest

Abstract read
In one paragraph

Article in Proceedings of SPIE--the International Society for Optical Engineering, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ti ZhangDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS USA 66045.
Huizhong CuiDepartment of Mechanical Engineering, Bioengineering Research Center, The University of Kansas, Lawrence, KS USA 66045.
Chia-Yi FangInstitute of Atomic and Molecular Science, Academia Sinica, Taipei, Taiwan 10617.
Janggun JoDepartment of Mechanical Engineering, Bioengineering Research Center, The University of Kansas, Lawrence, KS USA 66045.
Xinmai YangDepartment of Mechanical Engineering, Bioengineering Research Center, The University of Kansas, Lawrence, KS USA 66045.
Huan-Cheng ChangInstitute of Atomic and Molecular Science, Academia Sinica, Taipei, Taiwan 10617.
M Laird ForrestDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS USA 66045.

Funding

Biomaterials for treatment of head and neck cancerR01CA173292 · NCI · UNIVERSITY OF KANSAS LAWRENCE · PI FORREST, MARCUS LAIRD · 2013 to 2017
$1.4M
NCI NIH HHS R01 CA173292
6 · The paper itself

Abstract

Radiation-damaged nanodiamonds (NDs) are ideal optical contrast agents for photoacoustic (PA) imaging in biological tissues due to their good biocompatibility and high optical absorbance in the near-infrared (NIR) range. Acid treated NDs are oxidized to form carboxyl groups on the surface, functionalized with polyethylene glycol (PEG) and human epidermal growth factor receptor 2 (HER2) targeting ligand for breast cancer tumor imaging. Because of the specific binding of the ligand conjugated NDs to the HER2-overexpressing murine breast cancer cells (4T1.2 neu), the tumor tissues are significantly delineated from the surrounding normal tissue at wavelength of 820 nm under the PA imaging modality. Moreover, HER2 targeted NDs (HER2-PEG-NDs) result in higher accumulation in HER2 positive breast tumors as compared to non-targeted NDs after intravenous injection (i.v.). Longer retention time of HER-PEG-NDs is observed in HER2 overexpressing tumor model than that in negative tumor model (4T1.2). This demonstrates that targeting moiety conjugated NDs have great potential for the sensitive detection of cancer tumors and provide an attractive delivery strategy for anti-cancer drugs.

Indexed as

Breast CancerHER2NanodiamondPhotoacoustic Imaging

Identifiers

PMID25620857
PMCPMC4302273

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.